Peer Reviewed Publications

Flagship Pioneering and its portfolio companies make news because of their transformative approaches to solving global challenges. If you have needs beyond these resources, please contact press@flagshippioneering.com.

company

year

domain

Systemic messenger RNA as an etiological treatment for acute intermittent porphyria

Moderna 10.08.2018

Alginate encapsulation as long-term immune protection of allogeneic pancreatic islet cells transplanted into the omental bursa of macaques

Sigilon Therapeutics 08.13.2018

Enhancing T cell therapy through TCR-signalingresponsive nanoparticle drug delivery

07.09.2018

Biocompatible, Purified VEGF-A mRNA Improves Cardiac Function after Intracardiac Injection 1 Week Post-myocardial Infarction in Swine

Moderna 06.15.2018

A Novel Amino Lipid Series for mRNA Delivery: Improved Endosomal Escape and Sustained Pharmacology and Safety in Non-human Primates

Moderna 06.06.2018

Evolving Industry Partnerships and Investments in Cell and Gene Therapies

Sigilon Therapeutics 05.03.2018

Microneedle-based device for the one-step painless collection of capillary blood samples

YourBio Health 02.19.2018

Multi-antigenic human cytomegalovirus mRNA vaccines that elicit potent humoral and cell-mediated immunity

Moderna 02.15.2018

Systemic Messenger RNA Therapy as a Treatment for Methylmalonic Acidemia

Moderna 12.19.2017

Rhesus Macaque Myeloid-Derived Suppressor Cells Demonstrate T Cell Inhibitory Functions and Are Transiently Increased after Vaccination

Moderna 11.27.2017

Loading